Subscribe

Your FREE subscription will give you access to articles, research reports, Biopharma CEO Confidence quarterly reports and much more!

Sales and Go-to-Market Insights Sales-Related Case Studies and White Pages

Kineticos’ sales and marketing experts rely on their diverse and extensive backgrounds in the life science industries to provide customized sales and go-to-market strategies for a range of clients. Below are case studies, white papers, and articles written by the Kineticos team on a variety of subjects related to sales, marketing, and go-to-market strategies.

Click the Tabs Below for Sales and Go-to-Market Case Studies, White Papers & Articles, and Blog

 


Case Studies
Articles
Blog
  • Tradeoff Analysis and Valuation

    Situation: A preclinical precision medicine biotech company, looking to leverage their genome editing platform technology, was seeking support in narrowing

     

    Read this Case Study

  • Go-to-Market Strategy and Tactical Deployment Plan

    Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively

     

    Read this Case Study

  • Business Planning and Launch

    Situation: An emerging concierge patient healthcare services company was nearing launch and requested that Kineticos support the final stages of

     

    Read this Case Study

  • Functional Process Improvement

    Situation: A leading global contract research organization dissatisfied with their lab’s scientific affairs function retained Kineticos to conduct an operational

     

    Read this Case Study

  • Lab Integration Strategy

    Situation: A global bioanalytical lab specializing in large-molecule bioanalysis was experiencing challenges while integrating with their large, geographically distant partner.

     

    Read this Case Study

  • Central Lab Operational Excellence

    Situation: A global contract research organization was experiencing operational challenges within the central lab causing the business unit to perform

     

    Read this Case Study

  • A Primer on Demand Generation

    Written by Kevin Hampton, VP of Marketing, Kineticos Heading up Marketing for a start-up professional services company presents a variety

     

    Read this Article

  • Shaping Elite Performance

    Written by Abe Maingi, Senior Analyst, Kineticos Prior to starting my professional career as an analyst at Kineticos, my primary

     

    Read this Article

  • Amazing Science, Engaging Leaders, and Improved Outcomes

    Written by Mark Osterman, Senior Vice President, Kineticos As many parents have experienced at one point or another, my children

     

    Read this Article

  • Increasing Campus Recruiting in Research Triangle Park

    Written by Myung Soo Kim, PhD, Research Analyst, Kineticos Research Triangle Park (RTP), NC offers many attractive features for those

     

    Read this Article

  • Product Launch Metrics

    Written by Bill Finger, Executive Vice President & Managing Director, Kineticos With the culmination of a product created through open

     

    Read this Article

  • A Primer on Immuno-Oncology: Part 2 – Targeted Redirection of T Cells

    In addition to anticancer vaccines, cytokines, and immune checkpoint inhibitors, bispecific T cell engagers (BiTE) antibody (Ab) constructs, and chimeric

     

    Read this Article

  • How Metrics Can Help Identify and Solve Operational Challenges

    Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of

     

    Read this Blog Post

  • Growth by Acquisition in Life Sciences: Do You Have a Plan?

    Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as

     

    Read this Blog Post

  • R&D Revolutionaries: Why the Actavis/Allergan Deal Takes a Stand for Biopharma’s True Roots in Innovation

    James Forte of Kineticos takes an in-depth look at the recent Actavis/Allergan deal including the role R&D innovation played in shaping the deal’s outcome. Let’s be candid. It’s been awhile since any biopharma company was able to claim R&D as a core competency with a straight face. Biopharma’s R&D efforts have long been challenged, and rightly so given its output, but the Actavis/Allergan deal shows that the right investment in R&D can revolutionize a business. Could efficient R&D be the new definition of innovation?

     

    Read this Blog Post

  • Driving Revenue and EBIDTA at CROs through Customer Loyalty

    Article Preview Determining customer satisfaction and loyalty is a difficult endeavor for most businesses. Traditional voice of customer surveys are

     

    Read this Blog Post

  • Merck KGaA and Bayer Choose Opposite Strategies

    Article Preview Europe’s two largest chemical and drug conglomerates are changing course in starkly opposite ways. As reported in recent

     

    Read this Blog Post

  • Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships

    Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping

     

    Read this Blog Post


Contact Us Today to Discover How We Can Elevate Your Business Our Strategy Consulting Services Are Designed to Enhance Your Value

Contact Us Today
Top